Cargando…

A Favipiravir-induced Fever in a Patient with COVID-19

We herein report the first case of a fever induced by favipiravir, a potential coronavirus disease 2019 therapeutic drug. An 82-year-old man diagnosed with bilateral pneumonia was transferred to our hospital following a positive severe acute respiratory syndrome coronavirus 2 polymerase chain reacti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurita, Takashi, Ishida, Keiko, Muranaka, Emiri, Sasazawa, Hiroki, Mito, Haruki, Yano, Yudai, Hase, Ryota
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725626/ https://www.ncbi.nlm.nih.gov/pubmed/33191372 http://dx.doi.org/10.2169/internalmedicine.5394-20

Ejemplares similares

Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019
por: Hase, Ryota, et al.
Publicado: (2020)

A pitfall of cognitive bias during the pandemic: Two cases of Plasmodium falciparum malaria coinfected or misdiagnosed with COVID-19
por: Mito, Haruki, et al.
Publicado: (2023)

Enterobiasis in the hospitalized patient
por: Muranaka, Emiri, et al.
Publicado: (2023)

Potential for false-positive results with quantitative antigen tests for SARS-CoV-2: A case of a child with acute respiratory infection
por: Hase, Ryota, et al.
Publicado: (2022)

Tapeworm (Diphyllobothrium nihonkaiense) detected by abdominal ultrasonography
por: Hase, Ryota, et al.
Publicado: (2023)

Favipiravir-induced fever in coronavirus disease 2019: A report of two cases
por: Takoi, Hiroyuki, et al.
Publicado: (2020)

Catheter-related bloodstream Mycobacterium wolinskyi infection in an umbilical cord blood transplant recipient: a case report
por: Muranaka, Emiri, et al.
Publicado: (2022)

Evaluation of the seroprevalence of measles, rubella, mumps, and varicella and the requirement for additional vaccination based on the JSIPC guidelines among emergency medical technicians at eight fire stations in Narita, Japan: a project review
por: Hase, Ryota, et al.
Publicado: (2021)

Measles in a measles-eliminated country: A case report of a measles-infected postpartum mother and infant in Japan
por: Mito, Haruki, et al.
Publicado: (2021)

Favipiravir-Induced Drug Fever in a Young Adult COVID-19 Patient
por: Jadeja, Dhigishaba M, et al.
Publicado: (2021)

Favipiravir: Drug fever: case report
Publicado: (2021)

Lethal Mutagenesis of Rift Valley Fever Virus Induced by Favipiravir
por: Borrego, Belén, et al.
Publicado: (2019)

Drug Fever Due to Favipiravir Administration for the Treatment of a COVID-19 Patient
por: Tawara, Junsuke, et al.
Publicado: (2021)

A case of COVID-19 diagnosed with favipiravir-induced drug fever based on a positive drug-induced lymphocyte stimulation test
por: Murai, Yushi, et al.
Publicado: (2021)

Role of favipiravir in the treatment of COVID-19
por: Joshi, Shashank, et al.
Publicado: (2021)

Favipiravir for COVID-19 in a Patient on Hemodialysis
por: Hirai, Daisuke, et al.
Publicado: (2021)

Newly developed artificial intelligence algorithm for COVID-19 pneumonia: utility of quantitative CT texture analysis for prediction of favipiravir treatment effect
por: Ohno, Yoshiharu, et al.
Publicado: (2022)

Bacterial meningitis in the absence of cerebrospinal fluid pleocytosis: A case report and review of the literature
por: Hase, Ryota, et al.
Publicado: (2014)

Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases
por: Murohashi, Kota, et al.
Publicado: (2020)

Favipiravir‐induced nephrotoxicity in a patient with COVID‐19: A case report
por: Abdelbary, Asmaa A., et al.
Publicado: (2021)

A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome
por: Suemori, Koichiro, et al.
Publicado: (2021)

Population pharmacokinetics of favipiravir in patients with COVID‐19
por: Irie, Kei, et al.
Publicado: (2021)

Use of Favipiravir in Lactating Mother With COVID-19
por: Karabayır, Nalan, et al.
Publicado: (2021)

Hematological Malignancy Patients, COVID-19, and Favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Future of antivirals in COVID-19: The case of favipiravir
por: Kow, Chia Siang, et al.
Publicado: (2022)

Evaluation of the effect of favipiravir on patients with COVID-19
por: Kamali, Alireza, et al.
Publicado: (2023)

Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19
por: Yamazaki, Shingo, et al.
Publicado: (2021)

SEVERE SINUS BRADYCARDIA INDUCED BY FAVIPIRAVIR
por: Habib, Mhd Baraa, et al.
Publicado: (2021)

Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020
por: Veliziotis, Ioannis, et al.
Publicado: (2020)

Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir
por: Guner, Rahmet, et al.
Publicado: (2021)

Favipiravir: A new and emerging antiviral option in COVID-19
por: Agrawal, Umang, et al.
Publicado: (2020)

Effectiveness of favipiravir in COVID-19: a live systematic review
por: Özlüşen, Batu, et al.
Publicado: (2021)

A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19
por: Doi, Yohei, et al.
Publicado: (2020)

Effect of favipiravir and an anti-inflammatory strategy for COVID-19
por: Yamamura, Hitoshi, et al.
Publicado: (2020)

Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19
por: Irie, Kei, et al.
Publicado: (2020)

Favipiravir exposure and pregnancy outcome of COVID-19 patients
por: Tırmıkçıoğlu, Zeynep
Publicado: (2022)

Favipiravir and the Need for Early Ambulatory Treatment of COVID-19
por: Korman, Tony M.
Publicado: (2021)

PIONEER trial: favipiravir to treat moderate COVID-19
por: Shalhoub, Sarah
Publicado: (2023)

Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19
por: Jiravisitkul, Paveewan, et al.
Publicado: (2023)

Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever
por: Oestereich, Lisa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pln1gockt2r42n0fbtke28qr58